SEC ownership of GeoVax Labs, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000832489.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

L1 Capital Global Opportunities Master Fund, Ltd.

Comparable rows

20/31

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
20 of 31
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000832489
Issuer location
Smyrna, GA

Ownership snapshot

Top shareholders of GeoVax Labs, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
L1 Capital Global Opportu...
Comparable rows
20/31
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 5% 11 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-8 of 31 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

20 of 31 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
ARMISTICE CAPITAL, LLC 5%
INTRACOASTAL CAPITAL, LLC 5%
JANE STREET GROUP, LLC 4.3%
L1 Capital Global Opportunities M... 1.8%
Ayrton Capital LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 31 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13D/G
5%
$460,575
387,038 shares
$0 30 Jun 2026
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
$325,652
273,657 shares
$0 30 Jun 2026
JANE STREET GROUP, LLC
13F 13D/G
Company
4.3%
from 13D/G
$400,399
315,275 shares
— 30 Jun 2026
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
1.8%
$1,906,048
547,715 shares
$0 31 Dec 2025
Ayrton Capital LLC
13D/G
1.6%
$141,271
118,715 shares
-$5,583,166 30 Jun 2026
HRT FINANCIAL LP
13F
Company
13F
1.6%
$160,000
126,704 shares
— 30 Jun 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.27%
$26,811
21,112 shares
— 30 Jun 2026
TWO SIGMA SECURITIES, LLC
13F
Company
13F
0.14%
$13,566
10,682 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$5,498.

Buys
$5,498
Insiders: 1
Sells
$0
Insiders: 0
Net
+$5,498
Shares: +10,000
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 10,000 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 10,000 0 $5,498 $0 +$5,498

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-11 of 11 reporting-owner rows connected to GeoVax Labs, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
11
Largest Forms 3/4/5 holder
David A. Dodd
Net 12M change
+$5,498
Latest report
17 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
David A. Dodd President, CEO, Director $39,594 Filing P/S 17 Jun 2026
Mark W. Reynolds Cfo $15,133 Filing P/S 17 Jun 2026
John N. Spencer Jr. Director $11,766 +$5,498 +88% Filing P/S 17 Jun 2026
John W. Sharkey VP, Business Development $6,129 Filing P/S 17 Jun 2026
McKee Kelly T. Jr. Chief Medical Officer $2,340 Filing P/S 17 Jun 2026
Nicole Lemerond Director Mixed 17 Jun 2026
Mark J. Newman Chief Scientific Officer Mixed 17 Jun 2026
Jayne Morgan Director Mixed 17 Jun 2026
Dean G. Kollintzas Director Mixed 17 Jun 2026
Randal D. Chase Director Mixed 17 Jun 2026
Robert T. McNally Director Mixed 17 Jun 2026

Recent insider transactions for GeoVax Labs, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
John N. Spencer Jr. GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
Jayne Morgan GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
Robert T. McNally GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
Nicole Lemerond GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
Dean G. Kollintzas GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
Randal D. Chase GOVX Stock Option Award 6,000 6,000 17 Jun 2026 Direct
John W. Sharkey GOVX Stock Option Award 17,600 17,600 17 Jun 2026 Direct
Mark W. Reynolds GOVX Stock Option Award 17,600 17,600 17 Jun 2026 Direct
Mark J. Newman GOVX Stock Option Award 17,600 17,600 17 Jun 2026 Direct
McKee Kelly T. Jr. GOVX Stock Option Award 17,600 17,600 17 Jun 2026 Direct
David A. Dodd GOVX Stock Option Award 29,300 29,300 17 Jun 2026 Direct
John N. Spencer Jr. GOVX Common Stock Purchase 87.7% $5,498 $0.5498 10,000 21,402 17 Oct 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .